|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 6 of 25 found articles
| Title: |
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial |
| Author: |
Foley, John F Defer, Gilles Ryerson, Lana Zhovtis Cohen, Jeffrey A Arnold, Douglas L Butzkueven, Helmut Cutter, Gary Giovannoni, Gavin Killestein, Joep Wiendl, Heinz Smirnakis, Karen Xiao, Shan Kong, George Kuhelj, Robert Campbell, Nolan |
| Appeared in: |
The lancet neurology |
| Paging: | Volume 21 () nr. 7 pages 608-619 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 6 of 25 found articles
| << previous | next >> |